日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial

Elebsiran 和 PEG-IFNα 治疗慢性乙型肝炎感染：一项部分随机、开放标签的 II 期试验

期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-04049-z
Wong, Grace Lai-Hung; Yuen, Man-Fung; Lin, Bingliang; Douglas, Mark W; Hu, Peng; Xie, Qing; Lv, Fangfang; Tak, Won Young; Leerapun, Apinya; Kim, Dong Joon; Tangkijvanich, Pisit; Lim, Young-Suk; Dai, Chia-Yen; O'Beirne, James; Weltman, Martin; Khemnark, Suparat; Piratvisuth, Teerha; Manasirisuk, Witsarut; Chen, Xinyue; Liu, Chun-Jen; Heo, Jeong; Lee, Jooho; Niu, Junqi; Kumar, Rahul; Kumar, Rajneesh; Zhu, Chong; Cao, Ke; Tian, Alex; Chen, Xiaofei; Zhu, Qing; Margolis, David; Jia, Jidong; Hong, Zhi
炎症/感染
肝炎
发表日期：2026
文献求助 收藏

Lenalidomide combined with R-CHOP (R2-CHOP) in the treatment of newly diagnosed double-expressor diffuse large B-cell lymphoma: a prospective phase II clinical trial

来那度胺联合R-CHOP方案（R2-CHOP）治疗新诊断的双表达弥漫性大B细胞淋巴瘤：一项前瞻性II期临床试验

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01229-5
Liu, Yizhen; Zhang, Qunling; Lv, Fangfang; Liu, Xiaojian; Ji, Dongmei; Xia, Zuguang; Jin, Jia; Tao, Rong; Zhang, Wenhao; Li, Xiaoqiu; Zhang, Shengjian; Wang, Zezhou; Wang, Jiachen; Hong, Xiaonan; Cao, Junning
B细胞
HOP
淋巴瘤
CHOP
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Indirect Comparisons of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with R/R MCL: An Extended Follow-up Analysis

泽布替尼与奥瑞替尼治疗复发/难治性套细胞淋巴瘤患者疗效的间接比较：一项扩展随访分析

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03202-x
Deng, Lijuan; Song, Yuqin; Zhou, Keshu; Li, Dengju; Hu, Jianda; Zou, Dehui; Gao, Sujun; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Feng, Ru; Jin, Jie; Lv, Fangfang; Fang, Cheng; Xu, Sheng; Zhu, Jun
细胞生物学
淋巴瘤
发表日期：2025
文献求助 收藏

A case of thrombotic thrombocytopenic purpura induced by acute hepatitis E and successfully controlled by lymphoplasmapheresis plus rituximab

一例由急性戊型肝炎诱发的血栓性血小板减少性紫癜，经淋巴浆细胞分离术联合利妥昔单抗治疗后成功控制。

期刊:Virology Journal
影响因子:3.8
doi:10.1186/s12985-025-02649-2
Yu, Binfeng; Zhu, Yongfen; Jin, Zhihua; Han, Fei; Lv, Fangfang
细胞生物学
心血管
肝炎
血小板
发表日期：2025
文献求助 收藏

Selinexor combined with R-GDP as salvage therapy in relapsed/refractory diffuse large B-cell lymphoma

Selinexor联合R-GDP作为复发/难治性弥漫性大B细胞淋巴瘤的挽救治疗

期刊:American Journal of Cancer Research
影响因子:2.9
doi:10.62347/RKWU3795
Jiang, Shiyu; Li, Youli; Liu, Chuanxu; Liu, Yizhen; Zhang, Qunling; Lv, Fangfang; Zhang, Wenhao
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2025
文献求助 收藏

Trends in adolescent pertussis burden: a systematic analysis from 1990 to 2021 in global, regional, and national within the global burden of disease study 2021, with forecasts for 2046

青少年百日咳疾病负担趋势：基于2021年全球疾病负担研究的全球、区域和国家层面1990年至2021年的系统分析，并对2046年进行了预测。

期刊:Frontiers in Pediatrics
影响因子:2
doi:10.3389/fped.2025.1601110
Zhu, Huihui; Lv, Fangfang; Wen, Shunhang; Xu, Ming; Zhang, Hailin
微生物学
百日咳
发表日期：2025
文献求助 收藏

Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial

比较祖贝利单抗联合CHOP方案与利妥昔单抗联合CHOP方案治疗初治CD20阳性弥漫性大B细胞淋巴瘤患者的疗效：一项3期临床试验

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-008895
Li, Zhiming; Jiang, Wenqi; Zhou, Hui; Cen, Hong; Zhang, Mingzhi; Lv, Fangfang; Zhang, Qingyuan; Sun, Xiuhua; Liu, Lihong; Huang, Yunhong; Yang, Haiyan; Gao, Sujun; He, Chuan; Yang, Wei; Li, Wenyu; Yu, Ding; Yang, Yu; Cheng, Ying; Qian, Zhengzi; Xiang, Ying; Guo, Qunyi; Xu, Bing; Song, Yuqin; Zhang, Liling; Lin, Lie; Shen, Jianzhen; Yan, Feng; Liu, Huilan; Zhang, Donghua; Wang, Jishi; Zhou, Min; Zhu, Xiongpeng; Zhang, Weihua; Zhao, Weili; Feng, Ru; Zhang, Xiaohong; Jin, Jie; Zhong, Meizuo; Zhang, Mei; Wang, Jingbo; Jing, Hongmei; Wang, Zhao; Zhao, Hongguo; Zhu, Jun
B细胞
HOP
淋巴瘤
CHOP
CD20
细胞生物学
CD2
免疫/内分泌
发表日期：2024
文献求助 收藏

Primary seminal vesicle diffuse large B-cell lymphoma: a case report and review of the literatures

原发性精囊弥漫性大B细胞淋巴瘤：病例报告及文献复习

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1461090
Li, Youli; Cao, Sufen; Lv, Fangfang; Chen, Guang-Liang
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2024
文献求助 收藏

Chidamide plus R-GDP for relapsed/refractory diffuse large B-cell lymphoma in patients ineligible for autologous transplantation: A prospective, single-arm, phase II study

西达米德联合R-GDP治疗不适合自体移植的复发/难治性弥漫性大B细胞淋巴瘤患者：一项前瞻性、单臂、II期研究

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70142
Chen, Guang-Liang; Xue, Kai; Zhang, Qunling; Xia, Zu-Guang; Jin, Jia; Li, Ran; Liu, Yizhen; Lv, Fangfang; Hong, Xiaonan; Li, Xiaoqiu; Cao, Junning
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2024
文献求助 收藏

PD-1 inhibitors plus chemotherapy for refractory EBV-positive DLBCL: a retrospective analysis

PD-1抑制剂联合化疗治疗难治性EBV阳性弥漫性大B细胞淋巴瘤：一项回顾性分析

期刊:Blood Research
影响因子:2.8
doi:10.1007/s44313-024-00042-6
Li, Youli; Wu, Yonghe; Cao, Sufen; Yu, Baohua; Zhang, Qunling; Xia, Zuguang; Cao, Junning; Lv, Fangfang; Chen, Guang-Liang
B细胞
淋巴瘤
细胞生物学
PD-1
免疫/内分泌
发表日期：2024
文献求助 收藏